Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The Effect of Butyrate-Supplemented Parenteral Nutrition on Intestinal Defence Mechanisms and the Parenteral Nutrition-Induced Shift in the Gut Microbiota in the Rat Model

Z. Jirsova, M. Heczkova, H. Dankova, H. Malinska, P. Videnska, H. Vespalcova, L. Micenkova, L. Bartonova, E. Sticova, A. Lodererova, L. Prefertusová, A. Sekerkova, J. Hradecky, M. Cahova,

. 2019 ; 2019 (-) : 7084734. [pub] 20190228

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc19034668

Grant support
NV15-28745A MZ0 CEP Register

Butyrate produced by the intestinal microbiota is essential for proper functioning of the intestinal immune system. Total dependence on parenteral nutrition (PN) is associated with numerous adverse effects, including severe microbial dysbiosis and loss of important butyrate producers. We hypothesised that a lack of butyrate produced by the gut microbiota may be compensated by its supplementation in PN mixtures. We tested whether i.v. butyrate administration would (a) positively modulate intestinal defence mechanisms and (b) counteract PN-induced dysbiosis. Male Wistar rats were randomised to chow, PN, and PN supplemented with 9 mM butyrate (PN+But) for 12 days. Antimicrobial peptides, mucins, tight junction proteins, and cytokine expression were assessed by RT-qPCR. T-cell subpopulations in mesenteric lymph nodes (MLN) were analysed by flow cytometry. Microbiota composition was assessed in caecum content. Butyrate supplementation resulted in increased expression of tight junction proteins (ZO-1, claudin-7, E-cadherin), antimicrobial peptides (Defa 8, Rd5, RegIIIγ), and lysozyme in the ileal mucosa. Butyrate partially alleviated PN-induced intestinal barrier impairment and normalised IL-4, IL-10, and IgA mRNA expression. PN administration was associated with an increase in Tregs in MLN, which was normalised by butyrate. Butyrate increased the total number of CD4+ and decreased a relative amount of CD8+ memory T cells in MLN. Lack of enteral nutrition and PN administration led to a shift in caecal microbiota composition. Butyrate did not reverse the altered expression of most taxa but did influence the abundance of some potentially beneficial/pathogenic genera, which might contribute to its overall beneficial effect.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19034668
003      
CZ-PrNML
005      
20201023113914.0
007      
ta
008      
191007s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2019/7084734 $2 doi
035    __
$a (PubMed)30941370
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Jirsova, Zuzana $u Department of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague 4-140 21, Czech Republic.
245    14
$a The Effect of Butyrate-Supplemented Parenteral Nutrition on Intestinal Defence Mechanisms and the Parenteral Nutrition-Induced Shift in the Gut Microbiota in the Rat Model / $c Z. Jirsova, M. Heczkova, H. Dankova, H. Malinska, P. Videnska, H. Vespalcova, L. Micenkova, L. Bartonova, E. Sticova, A. Lodererova, L. Prefertusová, A. Sekerkova, J. Hradecky, M. Cahova,
520    9_
$a Butyrate produced by the intestinal microbiota is essential for proper functioning of the intestinal immune system. Total dependence on parenteral nutrition (PN) is associated with numerous adverse effects, including severe microbial dysbiosis and loss of important butyrate producers. We hypothesised that a lack of butyrate produced by the gut microbiota may be compensated by its supplementation in PN mixtures. We tested whether i.v. butyrate administration would (a) positively modulate intestinal defence mechanisms and (b) counteract PN-induced dysbiosis. Male Wistar rats were randomised to chow, PN, and PN supplemented with 9 mM butyrate (PN+But) for 12 days. Antimicrobial peptides, mucins, tight junction proteins, and cytokine expression were assessed by RT-qPCR. T-cell subpopulations in mesenteric lymph nodes (MLN) were analysed by flow cytometry. Microbiota composition was assessed in caecum content. Butyrate supplementation resulted in increased expression of tight junction proteins (ZO-1, claudin-7, E-cadherin), antimicrobial peptides (Defa 8, Rd5, RegIIIγ), and lysozyme in the ileal mucosa. Butyrate partially alleviated PN-induced intestinal barrier impairment and normalised IL-4, IL-10, and IgA mRNA expression. PN administration was associated with an increase in Tregs in MLN, which was normalised by butyrate. Butyrate increased the total number of CD4+ and decreased a relative amount of CD8+ memory T cells in MLN. Lack of enteral nutrition and PN administration led to a shift in caecal microbiota composition. Butyrate did not reverse the altered expression of most taxa but did influence the abundance of some potentially beneficial/pathogenic genera, which might contribute to its overall beneficial effect.
650    _2
$a zvířata $7 D000818
650    _2
$a biodiverzita $7 D044822
650    _2
$a butyráty $x farmakologie $7 D002087
650    _2
$a kolon $x účinky léků $x patologie $7 D003106
650    12
$a potravní doplňky $7 D019587
650    12
$a střevní mikroflóra $x účinky léků $7 D000069196
650    _2
$a regulace genové exprese $x účinky léků $7 D005786
650    _2
$a ileum $x účinky léků $x patologie $7 D007082
650    _2
$a tenké střevo $x účinky léků $7 D007421
650    _2
$a střeva $x patologie $7 D007422
650    _2
$a lymfatické uzliny $x účinky léků $x metabolismus $7 D008198
650    _2
$a lymfocyty $x účinky léků $x metabolismus $7 D008214
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a modely u zvířat $7 D023421
650    _2
$a muciny $x biosyntéza $7 D009077
650    _2
$a Panethovy buňky $x účinky léků $x metabolismus $7 D019879
650    12
$a parenterální výživa $7 D010288
650    _2
$a peptidy $x genetika $x metabolismus $7 D010455
650    _2
$a permeabilita $7 D010539
650    _2
$a fenotyp $7 D010641
650    _2
$a fylogeneze $7 D010802
650    _2
$a messenger RNA $x genetika $x metabolismus $7 D012333
650    _2
$a potkani Wistar $7 D017208
650    _2
$a proteiny těsného spoje $x metabolismus $7 D062725
655    _2
$a časopisecké články $7 D016428
700    1_
$a Heczkova, Marie $u Department of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague 4-140 21, Czech Republic.
700    1_
$a Dankova, Helena $u Department of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague 4-140 21, Czech Republic.
700    1_
$a Malinska, Hana $u Department of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague 4-140 21, Czech Republic.
700    1_
$a Videnska, Petra $u RECETOX, Faculty of Science, Masaryk University, Brno 625 00, Czech Republic.
700    1_
$a Vespalcova, Hana $u RECETOX, Faculty of Science, Masaryk University, Brno 625 00, Czech Republic.
700    1_
$a Micenkova, Lenka $u RECETOX, Faculty of Science, Masaryk University, Brno 625 00, Czech Republic.
700    1_
$a Bartoňová, Lenka $7 xx0248773 $u Clinical and Transplant Pathology Department, Institute for Clinical and Experimental Medicine, Prague 4-140 21, Czech Republic.
700    1_
$a Sticova, Eva $u Clinical and Transplant Pathology Department, Institute for Clinical and Experimental Medicine, Prague 4-140 21, Czech Republic.
700    1_
$a Lodererova, Alena $u Clinical and Transplant Pathology Department, Institute for Clinical and Experimental Medicine, Prague 4-140 21, Czech Republic.
700    1_
$a Prefertusová, Lucia $u Clinical and Transplant Pathology Department, Institute for Clinical and Experimental Medicine, Prague 4-140 21, Czech Republic.
700    1_
$a Sekerkova, Alena $u Prevedig, Prague 1-110 00, Czech Republic.
700    1_
$a Hradecky, Jaromir $u Faculty of Forestry and Wood Sciences, Czech University of Life Sciences, Prague, Czech Republic.
700    1_
$a Cahova, Monika $u Department of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague 4-140 21, Czech Republic.
773    0_
$w MED00182164 $t BioMed research international $x 2314-6141 $g Roč. 2019, č. - (2019), s. 7084734
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30941370 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20201023113912 $b ABA008
999    __
$a ok $b bmc $g 1451328 $s 1073218
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 2019 $c - $d 7084734 $e 20190228 $i 2314-6141 $m BioMed research international $n Biomed Res Int $x MED00182164
GRA    __
$a NV15-28745A $p MZ0
LZP    __
$a Pubmed-20191007

Find record

Citation metrics

Logged in users only

Archiving options